ConductScience.org, home

Gene · 6491

STIL: STIL centriolar assembly protein

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. STIL: STIL centriolar assembly protein. Genes, record 6491. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/6491

On this page

Gene

Symbol
STIL
HGNC
Name
STIL centriolar assembly protein
HGNC
NCBI Gene ID
6491
NCBI Gene
HGNC ID
HGNC:10879
HGNC
Ensembl
ENSG00000123473
NCBI Gene
Aliases
MCPH7, SIL
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
Q15468SCL-interrupting locus protein1,2875Ensembl, GeneID, HGNC

Source UniProt

Patents21

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1462724Q15468Espacenet
JP 2026004568 A2026-01-1462725Q15468Espacenet
JP 2026004568 A2026-01-1462726Q15468Espacenet
EP 4650780 A22025-11-197772Q15468Espacenet
EP 4641201 A22025-10-297848Q15468Espacenet
EP 4641202 A22025-10-295319Q15468Espacenet
JP 2025517969 A2025-06-127848Q15468Espacenet
JP 2025517970 A2025-06-127772Q15468Espacenet
KR 1020250017231 A2025-02-045319Q15468Espacenet
US 11446398 B22022-09-2076636Q15468Espacenet

1 to 10 of 21

See all 21 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants745

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleSTIL papersNewest fiscal year
P30CA008748Cancer Center Support Grant132025
P30CA021765Cancer Center Support Grant (CCSG)112025
ZIABC011459Control of centrosome biogenesis72025
R01GM088253Template-based replication of the centriole organelle62025
P30CA014520UW Comprehensive Cancer Center Support52025
P40OD010440Caenorhabditis Genetics Center52025
P30CA016672Cancer Center Support Grant42025
P30CA015083Mayo Clinic Comprehensive Cancer Center Support Grant32025
P30CA023074University of Arizona Cancer Center - Cancer Center Support Grant32025
R01AI078881Collaborative Integration of HCV Molecular Virology and Mathematical Modeling32025

1 to 10 of 745Source NIH's project files

See all 745 nih grants

Papers1,377

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Manual, digital, and AI tumour-infiltrating lymphocyte scoring: a secondary analysis of the APHINITY randomised trial.Lancet Oncol202642636838PubTator, text miningPubMed
Tumor-infiltrating lymphocytes density and distribution in breast cancer: A two-year study on their clinicopathological correlation.J Cancer Res Ther202642617026PubTator, text miningPubMed
Prognostic Value of Morphological Characteristics and Immune Microenvironment in High-Grade Serous Cancer (HGSC).Cancers (Basel)202642512390PubTator, text miningPubMed
Tertiary lymphoid structure-related genes drive tumor microenvironment heterogeneity and prognostic disparities in left- vs. right-sided colon cancer.Transl Cancer Res202642180948PubTator, text miningPubMed
Multi-omics analysis reveals the key role of STIL in Li-Fraumeni syndrome and osteosarcoma.NPJ Precis Oncol202642009739PubTator, text miningPubMed
Level of estrogen receptor expression, histological grade, and computationally assessed stromal TILs on pre-treatment biopsies predict pathological complete response to neoadjuvant chemotherapy in ER-positive/HER2-negative breast cancer.
Virchows Arch202642008179PubTator, text miningPubMed
Clinicopathological and molecular characteristics associated with pathological complete response in neoadjuvant immunotherapy for breast cancer.Front Immunol202641972153PubTator, text miningPubMed
Comparative Analysis of Stromal Tumor Infiltrating Lymphocytes in Various Grades and Molecular Subtypes of Breast Carcinoma.Ann Afr Med202641943585PubTator, text miningPubMed
[Clinical analysis of 7 cases of childhood acute lymphoblastic leukemia with PDGFRB rearrangement].Zhongguo Dang Dai Er Ke Za Zhi202641914417PubTator, text miningPubMed
Identification of Key Genes via Integrated Multi-Omics and Machine Learning Uncovers Tumor Biological Features and Prognostic Biomarkers in Uterine Leiomyosarcoma.Int J Med Sci202641799759PubTator, text miningPubMed

1 to 10 of 1,377

See all 1,377 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/6491

GET https://conductscience.org/api/genes/v1/6491/patents?page=2